353 related articles for article (PubMed ID: 27184366)
1. The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
Pullan ST; Allnutt JC; Devine R; Hatch KA; Jeeves RE; Hendon-Dunn CL; Marsh PD; Bacon J
BMC Infect Dis; 2016 May; 16():205. PubMed ID: 27184366
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315.
Jeeves RE; Marriott AA; Pullan ST; Hatch KA; Allnutt JC; Freire-Martin I; Hendon-Dunn CL; Watson R; Witney AA; Tyler RH; Arnold C; Marsh PD; McHugh TD; Bacon J
PLoS One; 2015; 10(9):e0138253. PubMed ID: 26382066
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.
Hu Y; Pertinez H; Ortega-Muro F; Alameda-Martin L; Liu Y; Schipani A; Davies G; Coates A
Antimicrob Agents Chemother; 2016 Aug; 60(8):4778-85. PubMed ID: 27216065
[TBL] [Abstract][Full Text] [Related]
4. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
[TBL] [Abstract][Full Text] [Related]
5. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
Hu Y; Coates AR; Mitchison DA
Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
[TBL] [Abstract][Full Text] [Related]
6. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
Zhang Y; Permar S; Sun Z
J Med Microbiol; 2002 Jan; 51(1):42-49. PubMed ID: 11800471
[TBL] [Abstract][Full Text] [Related]
7. Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages.
Heifets L; Higgins M; Simon B
Int J Tuberc Lung Dis; 2000 Jun; 4(6):491-5. PubMed ID: 10864178
[TBL] [Abstract][Full Text] [Related]
8. Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.
Grosset J; Truffot-Pernot C; Lacroix C; Ji B
Antimicrob Agents Chemother; 1992 Mar; 36(3):548-51. PubMed ID: 1622164
[TBL] [Abstract][Full Text] [Related]
9. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity.
Raynaud C; Lanéelle MA; Senaratne RH; Draper P; Lanéelle G; Daffé M
Microbiology (Reading); 1999 Jun; 145 ( Pt 6)():1359-1367. PubMed ID: 10411262
[TBL] [Abstract][Full Text] [Related]
11. [Nutrient starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis].
Chen ZF; Huang Q; Li YY; Zhang Y; Ren Y; Li KS; Fu ZJ; Xu SQ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 May; 30(5):359-62. PubMed ID: 17651643
[TBL] [Abstract][Full Text] [Related]
12. New mutations in pncA of in vitro selected pyrazinamide-resistant strains of Mycobacterium tuberculosis.
Bamaga M; Zhang H; Wright DJ
Microb Drug Resist; 2001; 7(3):223-8. PubMed ID: 11759083
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide.
Yang J; Liu Y; Bi J; Cai Q; Liao X; Li W; Guo C; Zhang Q; Lin T; Zhao Y; Wang H; Liu J; Zhang X; Lin D
Mol Microbiol; 2015 Mar; 95(5):791-803. PubMed ID: 25430994
[TBL] [Abstract][Full Text] [Related]
14. Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update.
Njire M; Tan Y; Mugweru J; Wang C; Guo J; Yew W; Tan S; Zhang T
Adv Med Sci; 2016 Mar; 61(1):63-71. PubMed ID: 26521205
[TBL] [Abstract][Full Text] [Related]
15. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
Pina RZ; Caleffi-Ferracioli KR; Campanerut-Sá PA; Ghiraldi-Lopez LD; Pavan FR; Siqueira VL; Scodro RB; Cardoso RF
Int J Tuberc Lung Dis; 2016 Nov; 20(11):1535-1538. PubMed ID: 27776597
[TBL] [Abstract][Full Text] [Related]
16. Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
Byrne ST; Denkin SM; Gu P; Nuermberger E; Zhang Y
J Med Microbiol; 2007 Aug; 56(Pt 8):1047-1051. PubMed ID: 17644711
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis.
Zimhony O; Cox JS; Welch JT; Vilchèze C; Jacobs WR
Nat Med; 2000 Sep; 6(9):1043-7. PubMed ID: 10973326
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model.
Naftalin CM; Verma R; Gurumurthy M; Lu Q; Zimmerman M; Yeo BCM; Tan KH; Lin W; Yu B; Dartois V; Paton NI
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739782
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]